Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in LoansChange in Net LoansDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northrim Bancorp (NRIM) Change in Accured Expenses: 2010-2024

Historic Change in Accured Expenses for Northrim Bancorp (NRIM) over the last 11 years, with Dec 2024 value amounting to $1.3 million.

  • Northrim Bancorp's Change in Accured Expenses fell 79.05% to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$5.5 million, marking a year-over-year decrease of 177.09%. This contributed to the annual value of -$5.5 million for FY2024, which is 177.09% down from last year.
  • As of Q4 2024, Northrim Bancorp's Change in Accured Expenses stood at $1.3 million, which was down 19.33% from $1.6 million recorded in Q3 2024.
  • In the past 5 years, Northrim Bancorp's Change in Accured Expenses registered a high of $9.4 million during Q4 2020, and its lowest value of -$7.9 million during Q1 2022.
  • Its 3-year average for Change in Accured Expenses is -$171,417, with a median of $1.3 million in 2022.
  • Per our database at Business Quant, Northrim Bancorp's Change in Accured Expenses skyrocketed by 900.25% in 2020 and then crashed by 785.74% in 2021.
  • Over the past 5 years, Northrim Bancorp's Change in Accured Expenses (Quarterly) stood at $9.4 million in 2020, then slumped by 154.90% to -$5.2 million in 2021, then surged by 127.41% to $1.4 million in 2022, then skyrocketed by 326.62% to $6.1 million in 2023, then crashed by 79.05% to $1.3 million in 2024.
  • Its Change in Accured Expenses stands at $1.3 million for Q4 2024, versus $1.6 million for Q3 2024 and -$5.2 million for Q2 2024.